Wall Street Analyst: McKesson Loses Contract, Best Buy Dips, Questcor a Buy
Best Buy Co. Inc.(NYSE:BBY): Cleveland Research’s checks indicate Best Buy has seen a significant slow-down in domestic top-line trends following the holiday period. Shares are Neutral rated.
Questcor Pharmaceuticals, Inc.(NASDAQ:QCOR): Jefferies says Questcor’s pre-announced Q4 Acthar sales of $75M topped the consensus estimate of $68.6M. The firm reiterates a Buy rating on the stock with a $50 price target.
MBIA Inc.(NYSE:MBI): MBIA mentioned positively at BTIG.
Idenix Pharmaceuticals Inc.(NASDAQ:IDIX): After Idenix announced that the FDA had lifted the partial clinical hold on IDX184 for HCV, Oppenheimer thinks the decision suggests there are no major safety signals in the ongoing ph.IIb study of the drug. The firm continues to see the 12-week safety results for the drug in 1H12 as a key for the stock ,as it believes that these results will affect talks with potential partners. The firm maintains a Perform rating based on valuation.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com